Top compounds associated with response to RPL21


Feature Type Standardized
Nominal ANOVA
mRNA PF-3758309 CTRPv2 pan-cancer AAC 0.19 0.0002
mRNA SNX-2112 CTRPv2 pan-cancer AAC 0.13 0.0002
mRNA docetaxel:tanespimycin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.14 0.0002
mRNA MLN4924 CTRPv2 pan-cancer AAC 0.14 0.0002
mRNA Irinotecan gCSI pan-cancer AAC 0.2 0.0003
mRNA dacarbazine CTRPv2 pan-cancer AAC 0.13 0.0003
mRNA piperlongumine:MST-312 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.14 0.0004
mRNA thalidomide CTRPv2 pan-cancer AAC -0.21 0.0005
mRNA decitabine CTRPv2 pan-cancer AAC 0.11 0.0005
mRNA Methotrexate CTRPv2 pan-cancer AAC 0.15 0.0006
Download CSV